|1.||Kopylov, F Yu: 1 article (01/2015)|
|2.||Cherny, O V: 1 article (01/2015)|
|3.||Mesitskaya, D F: 1 article (01/2015)|
|4.||Lomakin, O V: 1 article (01/2015)|
|5.||Nikitina, Yu M: 1 article (01/2015)|
|6.||Aksenova, M G: 1 article (01/2015)|
|7.||Dobrovolsky, A V: 1 article (01/2015)|
|8.||Hiraga, Takeo: 1 article (09/2014)|
|9.||Nijoukubo, Daisuke: 1 article (09/2014)|
|10.||Kitazawa, Takio: 1 article (09/2014)|
07/01/1996 - "Thromboxane synthetase inhibitor ameliorates delayed neuronal death in the CA1 subfield of the hippocampus after transient global ischemia in gerbils."
01/01/1986 - "This study was performed to examine potential protective effects of UK 38.485, an inhibitor of thromboxane synthetase, in canine myocardium stressed by transient ischemia. "
01/01/1987 - "Protective effects of selective inhibitor of thromboxane synthetase (OKY-046) and thromboxane antagonist (ONO-3708) on ischemia-induced mitochondrial dysfunction in canine heart."
04/01/1988 - "Platelets are suggested to exacerbate ischemia-induced myocardial injury, which has led to the study of various antiplatelet therapies including thromboxane synthetase inhibitors (TXSI). "
02/01/1999 - "The anti-thromboxane A2 synthetase activity of myocardial tissue and its variation during ischemia and reperfusion in isolated rabbit heart."
|2.||Septic Shock (Toxic Shock Syndrome)
06/01/1997 - "Protective effects of a thromboxane synthetase inhibitor and continuous arteriovenous hemofiltration in rat endotoxic shock."
06/01/1980 - "Protective effects of thromboxane synthetase inhibitors in rats in endotoxic shock."
05/01/1986 - "Improvement in organ blood flow by inhibition of thromboxane synthetase during experimental endotoxic shock in the rat."
01/01/1983 - "Thromboxane synthetase inhibitors in septic shock."
04/01/1983 - "Effects of a pyridine derivative thromboxane synthetase inhibitor and its inactive isomer in endotoxic shock in the rat."
04/01/1989 - "This study was carried out to test this hypothesis with a new thromboxane synthetase inhibitor, and to extend the studies to alternative animal models of myocardial infarction. "
10/01/1986 - "Development of an experimental model of acute myocardial infarction and the effects of a thromboxane synthetase inhibitor (OKY-046)."
03/01/1985 - "U-63,557A, a new selective thromboxane synthetase inhibitor, was evaluated for its ability to prevent the extension of myocardial infarct size. "
03/01/1985 - "Protective action of a thromboxane synthetase inhibitor in preventing extension of infarct size in acute myocardial infarction."
02/01/1991 - "Inhibition of thromboxane A2 synthetase failed to limit myocardial infarct size in a rabbit ischemia-reperfusion model."
06/01/1983 - "Protective effects of thromboxane A2 synthetase inhibitors on endotoxin shock."
09/01/1987 - "In some shock models, however, results with thromboxane synthetase inhibitors have been conflicting. "
07/01/1991 - "These data show that a selective thromboxane synthetase inhibitor (OKY-046) does not improve the blood rheology during endotoxin shock, although it seems to prevent the acidosis in some extent."
01/01/1988 - "Both 150 and 300 mg/kg doses of picotamide significantly (P less than 0.05) improved survival in endotoxin shock at 48 hr. These studies demonstrate that picotamide is a selective thromboxane synthetase inhibitor, and that it may be useful during disease states characterized by increased TxA2 synthesis."
02/15/1990 - "Protective effect of Y-20811, a long-lasting thromboxane synthetase inhibitor, on endotoxin shock in rabbits."
03/01/1992 - "Thromboxane synthetase inhibitors have been used successfully to treat experimentally induced glomerulonephritis in several species and this treatment appears to hold promise for naturally occurring glomerulonephritis in dogs."
10/01/1986 - "Effect of a thromboxane synthetase inhibitor on eicosanoid synthesis and glomerular injury during acute unilateral glomerulonephritis in the rat."
05/01/1992 - "Effects of a thromboxane synthetase inhibitor on established immune complex glomerulonephritis in dogs."
03/01/1991 - "Effects of thromboxane synthetase inhibition on immune complex glomerulonephritis."
10/01/1988 - "Effects of a specific thromboxane synthetase inhibitor on development of experimental Dirofilaria immitis immune complex glomerulonephritis in the dog."
|3.||Thromboxane A2 (A2, Thromboxane)
|5.||Aspirin (Acetylsalicylic Acid)
|8.||Thromboxane Receptors (Thromboxane Receptor)
|10.||Prostaglandin H2 Thromboxane A2 Receptors
|3.||Free Tissue Flaps